Skip to Main Content

Paper Details

A Composite Endpoint for Treatment Benefit According to Patient Preference.
Stat Biopharm Res
0
2022
Author NameAffiliation
Lorene M NelsonStanford University School of Medicine.
Lu TianStanford University School of Medicine.
Lu TianStanford University.
  • 1 - 3

Datasets

Release 1.2